Related references
Note: Only part of the references are listed.Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine
Annette M. May et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Myelodysplastic Syndromes
Mario Cazzola
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes
Kai Ding et al.
ONCOLOGY LETTERS (2016)
Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia
Hai Zhou et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients
Hyun Ae Jung et al.
ONCOTARGET (2015)
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS
Amer M. Zeidan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Current therapy of myelodysplastic syndromes
Amer M. Zeidan et al.
BLOOD REVIEWS (2013)
Myelodysplastic syndromes: toward a risk-adapted treatment approach
Bishoy Faltas et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes
Azra Raza et al.
NATURE REVIEWS CANCER (2012)
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
Lieke H. van der Helm et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate-or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
Michael Luebbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The effect of decitabine on megakaryocyte maturation and platelet release
Jianhui Wang et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Carlo Stresemann et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants
T Kawamoto
ARCHIVES OF HISTOLOGY AND CYTOLOGY (2003)
Share Paper
